Publisher
Springer Science and Business Media LLC
Subject
Management of Technology and Innovation,Health Policy,Issues, ethics and legal aspects,Health (social science)
Reference73 articles.
1. AMSA PharmFree Scorecard 2009. (2009). Executive summary updated. http://amsascorecard.org/executive-summary . Accessed 26 Sept 2010.
2. Andersen, M., Ktragstrup, J., & Søndergaard, J. (2006). How conducting a clinical trial affects physicians’ guideline adherence and drug preferences. JAMA, 295, 2759–2764.
3. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
4. Austin, P. C., Mamdani, M. M., Tu, K., & Jaakkimainen, L. (2003). Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women’s Health Initiative Study. JAMA, 289, 3241–3242.
5. Baker, D. (2008). The benefits and savings from publicly funded clinical trials of prescription drugs. International Journal of Health Services, 38, 731–750.
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献